Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SMARCD1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | DNMT1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | WASF1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | CEP295NL | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-07 |
mRNA | SRSF7 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | UBE3D | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | HEXB | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | TGS1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | RAVER1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | EXOSC8 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |